Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/neurobiology.2.006
EBV-positive Intravascular Large B-cell Lymphoma
Qingjiao Li1, Junpu Wang1,2*, Jinghe Li1,2
- 1Department of Pathology, Xiangya Hospital, Central South University, Changsha City, Hunan Province, China
- 2Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, China
Corresponding Author
Junpu Wang, wang-jp2013@csu.edu.cn
Received Date: July 14, 2020
Accepted Date: July 23, 2020
Li Q, Wang J, Li J. EBV-positive intravascular large B-cell lymphoma. J Neurobiol Physiol 2020; 2(1):9-11.
Copyright: © 2020 Li Q, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Gastric marginal zone B-cell lymphoma of MALT type – An updated histo- and molecular pathological summary
Gastric marginal zone lymphoma (gMZBL) is the most frequent type of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT). The histology of gMZBL shows typical small cell morphology, however, there also exists a large cell variant.
Clopidogrel pharmacogenetics in patients undergoing percutaneous neurointervention
During vascular neurointervention procedures, the use of double antiaggregation therapy (mainly acetylsalicylic acid and clopidogrel) is required to minimize the risk of thromboembolic complications.
EBV-positive Intravascular Large B-cell Lymphoma
Intravascular large B-cell lymphoma (IVLBCL) is a rare and specific variant of diffuse large B-cell lymphoma (DLBCL). Epstein-Barr virus (EBV)-positive IVLBCL is particularly rare and highly aggressive. Up to present, only a few cases of EBV-positive IVLBCL have been reported in the literature. Here, we would like to further explore its clinicopathological and molecular features to ensure the awareness and accurate diagnosis of this entity.
Sézary's syndrome: Review of the clinical, histomorphological and diagnostic aspects of a rare cutaneous lymphoma
Sézary's Syndrome consists of a rare type of non-Hodgkin cutaneous T-cell lymphoma (CTCL), being a very aggressive leukemic variant of CTCL. Given its rarity and its ability to mimic other more common diseases, this neoplasm represents a major diagnostic challenge for both clinicians and pathologists.
Dual targeting of plasma cells and B-cells to treat systemic lupus erythematosus
Autoimmune disorders, such as systemic lupus erythematosus, are associated with significant morbidity that is often ultimately refractory to current treatment modalities. To target the role of autoantibodies in disease pathogenesis, biologics have been designed for selective targeting of B-cells.